Salesforce Inc (CRM)
Salesforce: I Warned About The AI FOMO - But I'm Buying Now (Upgrade)
I warned about the extreme optimism on CRM stock in December 2023. My caution has panned out. Salesforce's AI monetization may take longer than expected, but the company remains confident in its long-term potential. Now, the market has become too pessimistic about CRM's growth potential, with a forward adjusted PEG ratio of just 1.2.
Value Act Capital Just Bought $99.79 Million of Salesforce (CRM) Stock
Shares of Salesforce (NYSE: CRM ) stock opened in the green following a significant purchase from ValueAct Capital. ValueAct's co-CEO and CIO, Mason Morfit, also serves as a director on the company's board, classifying the purchase as an insider transaction.
ValueAct increases Salesforce stake to nearly $1 billion, sending shares up
ValueAct has increased its stake in Salesforce to around 3.9 million shares worth $1 billion, via a $100 million trade earlier this week. Valueact co-CEO and Salesforce board member Mason Morfit disclosed the trade less than a week after the company reported its first revenue miss since 2006.
Salesforce opens London AI Centre under $4bn UK investment push
Salesforce Inc (NYSE:CRM, ETR:FOO) has opened its first AI Centre in London's Blue Fin Building, Southwark, signalling what the global CRM giant called “a vote of confidence in the United Kingdom's AI economy”. It forms part of Salesforce's $4 billion investment pledge into the UK's artificial intelligence sector.
Salesforce to open first AI centre in London
Salesforce has picked London for its first AI centre, where it said industry experts, developers and customers will be able to collaborate on innovation and develop new skills.
Salesforce to open new AI center in London as part of $4 billion UK investment
Salesforce said Thursday it will open its first, flagship artificial intelligence center in the U.K., in London's Blue Fin building. The center, part of Salesforce's $4 billion investment in the U.K., will be used to encourage industry collaboration as well as facilitate AI training and upskilling programs.
Salesforce Is Undervalued Despite A Democratizing AI Market
Salesforce stock dropped ~20% after Q1 fiscal 2025 earnings, missing revenue expectations by ~$14 million. The negative sentiment was in anticipation of future growth challenges, but largely unwarranted. Salesforce may face a future economy with highly democratized AI systems. This deflationary trend, also driven by mainstream robotics, may impact demand for Salesforce's current AI pricing in ~15 years. Despite risks, Salesforce remains a strong investment for the next decade. My conservative DCF model shows the company is roughly 20% undervalued. I reiterate my Buy rating.
What About Salesforce's Latest Report Upset Wall Street?
We also take a look at some companies that could ride the tailwinds of Nvidia's standout earnings.
3 SaaS Stocks to Buy Amid the Salesforce Drop
In the last week of May, SaaS stocks faced a reckoning. A revenue miss by Salesforce (NYSE: CRM ) triggered one of the sector's severest selloffs in two years.
Salesforce: Buy The Drop - A Rare Buying Opportunity
Salesforce, Inc. stock experienced a significant drop after its earnings report, creating a buying opportunity. Despite the minor revenue miss, Salesforce remains a high-quality company with growth potential and an attractive valuation. The market overreacted to slightly softer guidance, but Salesforce has a track record of beating estimates and has long-term growth potential.
Nvidia and Salesforce double down on AI startup Cohere in $450 million round, source says
Canadian AI startup Cohere has raised $450 million in funding from returning investors such as Nvidia and Salesforce Ventures , as well as new investors including Cisco and Canadian pension fund PSP Investments, according to a source familiar the matter.
Investors Heavily Search Salesforce Inc. (CRM): Here is What You Need to Know
Zacks.com users have recently been watching Salesforce.com (CRM) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
